ER Editor: A shoutout to Dr. Mike Yeadon for alerting us to this article on Telegram, a channel we highly recommend (see his entries for today, May 3). His reaction to this interesting news below:
Well, well, well. Colour me surprised. I can’t recall the anagram. Weren’t the names of purported “variants” by sheer coincidence able to be rearranged to spell “media control” or something similar? Best wishes Mike
To reassure readers, we still believe there were biological weapons seeded in certain areas. As Dr. Lee Merritt noted, Covid ‘infections’ tended to run along interstate highways in the US (as well as be deliberately confounded with flu). Yeadon believes something was seeded, too.
Recall what we put out the other day about Dr. Stefan Lanka (German Biologist Stefan Lanka Bet €100,000 the Measles Virus Doesn’t Exist. He Won.). If you’ve got a real virus in your test tube, then you should be able to re-infect people with it. AND be able to test the supposed efficacy of the treatments you’ve developed for it.
We question all uses of the word ‘natural’ in the article below.
********
Scientists tried to give people COVID — and failed
Researchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and treatments.
EWEN CALLAWAY for NATURE
When Paul Zimmer-Harwood volunteered to be intentionally infected with SARS-CoV-2, he wasn’t sure what to expect. He was ready for a repeat of his first brush with COVID-19, through a naturally acquired infection (ER: hmmm) that gave him influenza-like symptoms. But he hoped his immunity would help him feel well enough to use the indoor bicycle trainer that he had brought into quarantine.
It turned out that Zimmer-Harwood, a PhD student at University of Oxford, UK, had nothing to worry about. Neither he nor any of the 35 other people who participated in the ‘challenge’ trial actually got COVID-19.
The study’s results, published on 1 May in Lancet Microbe1, raise questions about the usefulness of COVID-19 challenge trials for testing vaccines, drugs and other therapeutics. “If you can’t get people infected, then you can’t test those things,” says Tom Peacock, a virologist at Imperial College London. Viral strains used in challenge trials take many months to produce, making it impossible to match emerging circulating variants that can overcome high levels of existing immunity in populations.
Researchers use challenge trials to understand infections and quickly test vaccines and therapies. In March 2021, after months of ethical debate, UK researchers launched the world’s first COVID-19 challenge trial. The study2 identified a minuscule dose of the SARS-CoV-2 strain that circulated in the early days of the pandemic that could infect about half of the participants, who had not previously been infected with the virus (at that time, vaccines weren’t yet widely available).
In parallel, a team led by Helen McShane, an infectious-disease researcher at Oxford, launched a second SARS-CoV-2 challenge study in people — including Zimmer-Harwood — who had recovered from naturally caught SARS-CoV-2 infections, caused by a range of variants. The trial later enrolled participants who had also been vaccinated.
Evolving strains
The first participants got the same tiny dose of the ‘ancestral’ SARS-CoV-2 strain as did those in the first trial. When nobody developed a sustained infection, the researchers increased the dose by more and more in subsequent groups of participants, until they reached a level 10,000 times the initial dose. A few volunteers developed short-lived infections, but these quickly vanished.
“We were quite surprised,” says Susan Jackson, a study clinician at Oxford and co-author of the latest study. “Moving forward, if you want a COVID challenge study, you’re going to have to find a dose that infects people.”
Despite their immunity to the ancestral strains, nearly 40% of the participants experienced an Omicron infection after being released from quarantine by December 2022, and one even got it twice.
An ongoing COVID-19 challenge trial at Imperial College London, in which participants have been exposed to the Delta SARS-CoV-2 variant, has also encountered problems with infecting participants reliably, says Christopher Chiu, an immunologist and infectious-disease physician at Imperial who is leading that trial and was involved in the other challenge trials. Some participants have experienced infections, but probably not enough for a study testing whether a vaccine works, adds Chiu.
CONTINUE READING HERE
************
Published to The Liberty Beacon from EuropeReloaded.com
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Researchers should’ve called Fauci and asked for a few vials of whatever it is his agencies are using to infect people with. Would’ve saved them a lot of trouble.